Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV-related health complications and treatments, and HIV/AIDS Research and Interventions.
Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies
Mpox in people with advanced HIV infection: a global case series
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus
Pillars of long-term antiretroviral therapy success
Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study
Contribution of alcohol use in <scp>HIV</scp>/hepatitis C virus co‐infection to all‐cause and cause‐specific mortality: A collaboration of cohort studies
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium
Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infection
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity
Risk for Non–AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study)
Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE
Reorienting health systems to care for people with HIV beyond viral suppression
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
Increased non‐ <scp>AIDS</scp> mortality among persons with <scp>AIDS</scp> ‐defining events after antiretroviral therapy initiation
Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy
Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study
CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990–2014
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study